- TWD2.48bn
- TWD3.66bn
- TWD2.68bn
- 16
- 54
- 49
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,673 | 1,638 | 2,226 | 2,714 | 2,682 |
Cost of Revenue | |||||
Gross Profit | 268 | 421 | 420 | 422 | 316 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,662 | 1,455 | 2,077 | 2,629 | 2,743 |
Operating Profit | 10.5 | 183 | 149 | 84.9 | -60.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 78.7 | 262 | 250 | 120 | -4.16 |
Provision for Income Taxes | |||||
Net Income After Taxes | 53.2 | 208 | 194 | 49.3 | -205 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 50.9 | 207 | 192 | 29.9 | -227 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 50.9 | 209 | 199 | 29.9 | -227 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.681 | 2.98 | 2.66 | 0.472 | -2.99 |
Dividends per Share |